Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-18-008430
Filing Date
2018-12-13
Accepted
2018-12-13 13:56:50
Documents
2
Period of Report
2018-12-11

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 8050
2 POWER OF ATTORNEY exh_241.htm EX-24.1 5506
  Complete submission text file 0001171843-18-008430.txt   14892
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XENON PHARMACEUTICALS INC. 200 - 3650 GILMORE WAY BURNABY A1 V5G4W8
Business Address
COHEN CHARLES J. (Reporting) CIK: 0001619967 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36687 | Film No.: 181232793